Cargando…
Amylin as a Future Obesity Treatment
Obesity is defined as abnormal or excessive fat accumulation that contributes to detrimental health impacts. One-third of the population suffers from obesity, and it is important to consider obesity as a chronic disease requiring chronic treatment. Amylin is co-secreted with insulin from β pancreati...
Autores principales: | Dehestani, Babak, Stratford, Nicholas RS, le Roux, Carel W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for the Study of Obesity
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735818/ https://www.ncbi.nlm.nih.gov/pubmed/34929674 http://dx.doi.org/10.7570/jomes21071 |
Ejemplares similares
-
Clinical Impact of Liraglutide as a Treatment of Obesity
por: Alruwaili, Heshma, et al.
Publicado: (2021) -
The Role of the Small Bowel in Unintentional Weight Loss after Treatment of Upper Gastrointestinal Cancers
por: Dehestani, Babak, et al.
Publicado: (2019) -
Amylin – Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity
por: Boyle, Christina Neuner, et al.
Publicado: (2017) -
Amylin in the Periphery
por: Wookey, Peter J., et al.
Publicado: (2003) -
Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
por: Singh, Som, et al.
Publicado: (2022)